Status:
COMPLETED
Assessment of Pain in People With Thalassemia Who Are Treated With Regular Blood Transfusions
Lead Sponsor:
Carelon Research
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Thalassemia
Eligibility:
All Genders
18+ years
Brief Summary
Thalassemia is an inherited blood disorder that can result in mild to severe anemia. Regular blood transfusions, which refresh the healthy red blood cell supply, are one treatment for thalassemia. Peo...
Detailed Description
Thalassemia is an inherited blood disorder in which the body makes an abnormal form of hemoglobin-the protein in red blood cells that carries oxygen. People with thalassemia often experience fatigue, ...
Eligibility Criteria
Inclusion
- Participating in the Thalassemia Clinical Research Network Assessment of Pain study
- Has a transfusion dependence of at least eight transfusions per year
- Diagnosis of beta thalassemia or E-beta-thalassemia
- Experiences at least "mild" pain in the 1 month before study entry, as measured by the response to the Brief Pain Inventory (BPI) question #6 from the Assessment of Pain study
Exclusion
- Unwillingness or inability to complete the Brief Pain Inventory Short Form (BPI-SF) on a daily basis
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00872833
Start Date
July 1 2009
End Date
October 1 2010
Last Update
October 7 2015
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Los Angeles
Los Angeles, California, United States, 90027
2
Children's Hospital Research Center Oakland
Oakland, California, United States, 94609
3
Stanford University - School of Medicine
Stanford, California, United States, 94305
4
Children's Healthcare of Atlanta
Atlanta, Georgia, United States, 30342